Comparative Imaging of XTR004 PET and MIBI SPECT in Borderline Coronary Stenosis

Exclusion Criteria

• •1\. Patients with a history of percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG).
• •2.Patients with a prior diagnosis of myocardial infarction, congenital heart disease, cardiomyopathy, myocarditis, or other cardiac diseases.
• •3.Patients known to have severe allergic reactions to alcohol.
• •4.Patients known to have an allergy or other contraindications to adenosine.
• •5.Patients known to be allergic to iodinated contrast agents.
• •6.Individuals with significant occupational exposure to ionizing radiation within the past 10 years (e.g., exceeding 50 mSv/year), or exposure to radioactive substances or ionizing radiation for therapeutic or research purposes.
• •7.Men and women of childbearing potential who do not plan to use effective contraception during the study and for 6 months after study completion (effective methods include sterilization, intrauterine hormonal devices, condoms, contraceptive pills/agents, abstinence, or partner vasectomy/tubal ligation).
• •8.Pregnant or lactating women.
• •9.Patients with claustrophobia, bipolar disorder, other psychiatric disorders, or poor compliance.
• •10.Patients who participated in another investigational drug clinical study within 30 days prior to enrollment or plan to do so during follow-up.
• •11.Any other condition that, in the opinion of the investigators, makes the patient unsuitable for participation.